Natera, Inc. Europe, Middle East, India, Africa — Total revenues increased by 7.0% to $6.43M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $6.05M to $6.43M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful international market penetration and growing demand for genetic testing services in these regions, while a decrease may indicate regulatory hurdles, competitive pressure, or challenges in local distribution partnerships.
This metric represents the total revenue generated by the company from diagnostic testing services and research collabor...
Comparable to international geographic revenue segments reported by other global diagnostic and life sciences companies, often evaluated based on regional market share and local healthcare reimbursement trends.
ntra_segment_europe_middle_east_india_africa_total_revenues| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.27M | $5.60M | $3.69M | $3.74M | $4.96M | $5.20M | $5.62M | $5.26M | $5.18M | $5.44M | $7.72M | $6.05M | $5.41M | $6.01M | $6.43M |
| QoQ Change | — | +31.3% | -34.1% | +1.2% | +32.7% | +4.8% | +8.2% | -6.5% | -1.5% | +5.0% | +42.0% | -21.7% | -10.6% | +11.1% | +7.0% |
| YoY Change | — | — | — | -12.4% | -11.5% | +40.8% | +50.4% | +6.0% | -0.3% | -3.2% | +46.9% | +16.8% | -0.6% | -22.2% | +6.2% |